Clinical Trial Update: Obsidio™ Conformable Embolic Registry

View source ↗

Summary

The Obsidio Conformable Embolic Registry trial sponsored by Boston Scientific has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage
• Hypervascular Tumors

Drugs mentioned

• Obsidio Conformable Embolic

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Hypervascular Tumors, Bleeding | Status: COMPLETED